Found 85 matching trials
IDegLira HIGH Trial
PHASE3Basal-bolus insulin therapy is recommended for patients with poorly control...
Location
Grady Health System
A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 Diabetes
PHASE1This trial was conducted in Europe. The aim of this study was to investigat...
Location
Novo Nordisk Investigational Site
Investigation of the Response Relationship of NN5401 in Type 1 Diabetics
PHASE1This trial was conducted in Europe. The aim of this clinical trial was to e...
Location
Novo Nordisk Investigational Site
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
PHASE4BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Location
Unit of Endocrinology and Metabolic Diseases
A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice
N/AThe purpose of the study is to collect information on how Ryzodeg® works in...
Location
Royal North Shore Hospital
Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
NAIn this prospective, randomized, open-label, parallel group trial, the safe...
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes
PHASE1This trial is conducted in Europe. The aim of the trial is to test for bioe...
Location
Multiple Locations
Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes
PHASE3This trial is conducted in Africa, Asia, Europe and the United States of Am...
Location
Novo Nordisk Investigational Site
Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes
PHASE2This trial is conducted in Europe. The aim of this trial is to compare two ...
Location
Novo Nordisk Investigational Site
CGM-guided Patch Pump vs Basal-Bolus Injection for Steroid-Induced Hyperglycemia in Sudden Sensorineural Hearing Loss: SHIP Trial
NAThis exploratory randomized controlled trial evaluates whether a CGM-guided...
Location
Multiple Locations